Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibodies
Biotech
Avalo snaps up AlmataBio for ex-Lilly inflammatory drug
Avalo is handing over more than $22 million to acquire AlmataBio for a phase 2-ready monoclonal antibody for hidradenitis suppurativa.
James Waldron
Mar 28, 2024 8:26am
GSK, Vir end flu drug alliance, removing key piece of $345M pact
Feb 23, 2024 5:10am
BioNTech pays WuXi $20M for 2 preclinical monoclonal antibodies
Jan 11, 2024 9:23am
NextCure jettisons mAB to focus on ADC aimed at same target
Dec 14, 2023 9:13am
Agomab uses $100M series C to push Crohn's drug through phase 2
Oct 11, 2023 8:50am
ModeX nets up to $168M in BARDA bucks to cook up new antibodies
Sep 29, 2023 10:43am